Atogepant
157 interactions 1 explained in plain English 45 cited references
Also sold as:
Qulipta
Qulipta®
About Atogepant
Atogepant is a calcitonin gene-related peptide receptor antagonist used to help prevent migraine headaches. Read the full Atogepant drug information page →
Medically reviewed by
Dr. Brian Staiger, PharmD, BCPS
· Updated Jul 12, 2026
· Editorial policy
· Data sources
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Most serious with:
Ensitrelvir
Nafcillin Injection
Voxilaprevir
Voriconazole
Voclosporin
Vinblastine
Major
Atogepant Telithromycin Increased atogepant exposure Details Atogepant Telmisartan Micardis Increased atogepant exposure Details Atogepant Telotristat Ethyl Xermelo Reduced atogepant exposure Details Atogepant Terbinafine Lamisil Reduced atogepant exposure Details Atogepant Thioridazine Reduced atogepant exposure Details Atogepant Ticagrelor Brilinta Reduced atogepant exposure Details Atogepant Ticlopidine Ticlid® Reduced atogepant exposure Details Atogepant Topiramate Eprontia Reduced atogepant exposure Details Atogepant Tovorafenib Ojemda Reduced atogepant exposure Details Atogepant Trofinetide Daybue Increased CYP3A substrate exposure and an increased risk of CYP3A substrate-related toxicities Details Atogepant Troglitazone Reduced atogepant exposure Details Atogepant Troleandomycin Increased atogepant exposure Details Atogepant Tucatinib Tukysa Increased atogepant exposure Details Atogepant Upadacitinib Rinvoq Reduced atogepant exposure Details Atogepant Ursodiol Actigall® Increased atogepant exposure Details Atogepant Velpatasvir Increased atogepant exposure Details Atogepant Vemurafenib Zelboraf Reduced atogepant exposure Details Atogepant Vinblastine Velban® Reduced atogepant exposure Details Atogepant Voclosporin Lupkynis Increased OATP1B1/OATP1B3 substrate exposure Details Atogepant Voriconazole Vfend Increased atogepant exposure Details Atogepant Voxilaprevir Increased atogepant exposure Details Atogepant Zanubrutinib Brukinsa Reduced atogepant exposure Details Atogepant Bexarotene Topical Targretin Reduced atogepant exposure Details Atogepant Brivaracetam Injection Briviact Reduced atogepant exposure Details Atogepant Cyclosporine Injection Atopica Increased atogepant exposure Details Atogepant Cyclosporine Ophthalmic Cequa Increased atogepant exposure Details Atogepant Dexamethasone Injection Decadron Reduced atogepant exposure Details Atogepant Dexamethasone Ophthalmic Dexacidin® (as a combination product containing Dexamethasone, Neomycin, Polymyxin B) Reduced atogepant exposure Details Atogepant Ketoconazole Topical Extina® Foam Increased atogepant exposure Details Atogepant Lenacapavir Injection Sunlenca Increased sensitive CYP3A substrate exposure and an increased risk of sensitive CYP3A substrate-mediated adverse reactions Details Atogepant Lenacapavir Oral Sunlenca Increased sensitive CYP3A substrate exposure and an increased risk of sensitive CYP3A substrate-mediated adverse reactions Details Atogepant Letermovir Injection Prevymis Increased atogepant exposure Details Atogepant Nafcillin Injection Unipen® Injection Reduced atogepant exposure DetailsModerate
Atogepant Artemether Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Atogepant Kratom Increased CYP3A substrate exposure Details Atogepant Mavacamten Camzyos Reduced CYP3A4 substrate exposure and reduced efficacy of CYP3A4 substrate Details Atogepant Rilzabrutinib Wayrilz Increased CYP3A substrate exposure and an increased risk of CYP3A substrate-related adverse reactions DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacistEducational information only, not medical advice. Always confirm interactions with your pharmacist
or prescriber before making any change to your medications.